3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Multiple Myeloma
2
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Mesothelioma, Malignant
1
Melanoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Carcinoma, Squamous Cell
1
Interventions
mogamulizumab
7
Specimen Handling
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
Biopsy
5
pembrolizumab
4
fludarabine
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
hypericin
3
fludarabine phosphate
3
cemiplimab
3
Radiotherapy
3
Nivolumab
3
sodium-iodide symporter
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Phototherapy
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Busulfan
2
talimogene laherparepvec
1
ruxolitinib
1
romidepsin
1
magrolimab
1
duvelisib
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
In Situ Hybridization, Fluorescence
×
1 year
×
Clear all
No trials found.